How Personalized Medicine Improves Patient Care
Not every drug works for every patient. The traditional trial-and-error method to prescribe therapy, at times, lead to adverse drug reactions (ADRs) and reduced drug efficacy. Thanks to the rapidly developing genomic medicine technologies, we have uncovered the associations between individual’s genetic profiles and response to certain drugs. This scientific breakthrough is called Pharmacogenomics, or PGx.
RPRD was founded in 2017 by scientists and clinicians from the Medical College of Wisconsin to use the PGx knowledge to personalize therapy, boosting drug safety and efficacy.